Literature DB >> 23011807

Treatment of dyssomnias and parasomnias in childhood.

Suresh Kotagal1.   

Abstract

OPINION STATEMENT: Dyssomnias are sleep disorders associated with complaints of insomnia or hypersomnia. The daytime sleepiness of narcolepsy is treated by a combination of planned daytime naps, regular exercise medications such as modafinil, or salts of methylphenidate, or amphetamine. Cataplexy that accompanies narcolepsy is treated with anticholinergic agents, selective serotonin reuptake inhibitors, or sodium oxybate. Children with neurodevelopmental disabilities such as autism have sleep initiation and maintenance difficulties on a multifactorial basis, with favorable response to melatonin in some patients. Childhood onset restless legs syndrome is often familial, associated with systemic iron deficiency, and responsive to iron supplementation and gabapentin. Parasomnias are episodic phenomena events which occur at the sleep -- wake transition or by intrusion on to sleep. Arousal parasomnias such as confusional arousals and sleep walking can sometimes be confused with seizures. A scheme for differentiating arousal parasomnias from nocturnal seizures is provided. Since arousal parasomnias are often triggered by sleep apnea, restless legs syndrome, or acid reflux, treatment measures directed specifically at these disorders often helps in resolution. Clonazepam provided in a low dose at bedtime can also alleviate sleep walking and confusional arousals. Obstructive sleep apnea affects about 2 percent of children. Adeno-tonsillar hypertrophy, cranio-facial anomalies, and obesity are common predisposing factors. Mild obstructive sleep apnea can be treated using a combination of nasal corticosteroids and a leukotriene antagonist. Moderate to severe obstructive sleep apnea are treated with adeno-tonsillectomy, positive airway pressure breathing devices, or weight reduction as indicated. This paper provides an overview of the topic, with an emphasis on management steps. Where possible, the level of evidence for treatment recommendations is indicated.

Entities:  

Year:  2012        PMID: 23011807     DOI: 10.1007/s11940-012-0199-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  68 in total

Review 1.  Kleine-Levin syndrome: current status.

Authors:  Yu-Shu Huang; Clair Lakkis; Christian Guilleminault
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

2.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

3.  PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome.

Authors:  Delphine Trochet; Louise M O'Brien; David Gozal; Ha Trang; Agneta Nordenskjöld; Béatrice Laudier; Pär-Johan Svensson; Sabine Uhrig; Trevor Cole; Stephan Niemann; Arnold Munnich; Claude Gaultier; Stanislas Lyonnet; Jeanne Amiel
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

Review 4.  Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies.

Authors:  Amanda L Richdale; Kimberly A Schreck
Journal:  Sleep Med Rev       Date:  2009-04-24       Impact factor: 11.609

Review 5.  The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents.

Authors:  Stijn L Verhulst; Luc Van Gaal; Wilfried De Backer; Kristine Desager
Journal:  Sleep Med Rev       Date:  2008-04-11       Impact factor: 11.609

6.  Hirschsprung's disease, Ondine's curse, and neuroblastoma--manifestations of neurocristopathy.

Authors:  J E Roshkow; J O Haller; W E Berdon; S M Sane
Journal:  Pediatr Radiol       Date:  1988

Review 7.  Parasomnias in childhood.

Authors:  Suresh Kotagal
Journal:  Sleep Med Rev       Date:  2008-12-06       Impact factor: 11.609

Review 8.  Narcolepsy in childhood.

Authors:  Sona Nevsimalova
Journal:  Sleep Med Rev       Date:  2009-01-18       Impact factor: 11.609

Review 9.  Treatment of narcolepsy and other hypersomnias of central origin.

Authors:  Merrill S Wise; Donna L Arand; R Robert Auger; Stephen N Brooks; Nathaniel F Watson
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

Review 10.  Epidemiology of pediatric obstructive sleep apnea.

Authors:  Julie C Lumeng; Ronald D Chervin
Journal:  Proc Am Thorac Soc       Date:  2008-02-15
View more
  3 in total

Review 1.  Management of sleep disorders among children and adolescents with neurodevelopmental disorders: A practical guide for clinicians.

Authors:  Michael O Ogundele; Chinnaiah Yemula
Journal:  World J Clin Pediatr       Date:  2022-03-15

Review 2.  Therapeutic Symptomatic Strategies in the Parasomnias.

Authors:  Raffaele Manni; Gianpaolo Toscano; Michele Terzaghi
Journal:  Curr Treat Options Neurol       Date:  2018-06-05       Impact factor: 3.598

Review 3.  Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions.

Authors:  Christian Popow; Susanne Ohmann; Paul Plener
Journal:  Neuropsychiatr       Date:  2021-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.